Physician profile
Brian Patrick Bradbee
NPI 1114332566
$1,616.60
in general payments reported to CMS, 2019-2025
17 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $55.00 · 2022: $321 · 2023: $313 · 2024: $649 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $327.31 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $291.60 | 2022-2025 | |
| Exact Sciences Corporation | $197.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $114.77 | 2022-2025 | Evenity, Prolia, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.91 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $93.34 | 2021-2024 | Wegovy, Rybelsus, Ozempic |
| Pfizer INC. | $92.19 | 2022-2024 | |
| Lilly USA, LLC | $81.14 | 2022-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $68.23 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $67.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.84 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $48.86 | 2021-2022 | |
| Inspire Medical Systems, INC. | $20.84 | 2024 | Inspire |
| E.R. Squibb & Sons, L.L.C. | $17.94 | 2022 | |
| Genentech USA, INC. | $14.89 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.73 | 2022 | |
| Bausch Health US, LLC | $11.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bradbee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.